Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Clinical trial NCT02160626 · COMPLETED
Trial details
- NCT number
- NCT02160626
- Sponsor
- Aclaris Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2014-12-01
- Enrollment
- 172
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.